Previous contradictory study has addressed its clinical significance in pediatric B-acute lymphoblastic leukemia (B-ALL) patients [37], and Kuang et al. [38] identified MPO as a risk gene in AML patients. The gene discussed is MPO; the disease is precursor B-cell acute lymphoblastic leukemia.